While most people vaccinate according to the recommended schedule, this success is
challenged by individuals and groups who delay or refuse vaccines. The aim of this article is …

Despite vaccines' effectiveness in reducing the rate of preventable diseases, vaccine
hesitancy has threatened public health and economies worldwide. Healthcare …

Cervical cancer can be cured, because it has a long preinvasive period. Early diagnosis and
treatment of cervical cancer at women are crucial for reducing of rate mortality. Today, there …

Background: Cervical cancer, the most common cancer among women in Tanzania is
strongly linked to Human Papilloma Virus. Precancerous lesions can be detected by …

Background and objective Two human papillomavirus vaccines were licenced in 2006/2007
for cervical cancer prevention. National vaccination programmes for schoolgirls were …

The quadrivalent human papillomavirus virus vaccine was recently licensed for use in males
in the United States. This study reviews available published literature on acceptability …

Human papillomavirus (HPV) is the causative agent in cervical cancer and has been
implicated in a range of other malignancies. Preventative vaccines are now internationally …

Objectives: To assess the level of knowledge regarding cervical cancer and the acceptance
of the human papilloma virus (HPV) vaccine among Saudi female students in health …

The quadrivalent vaccine has been shown to be safe and efficacious against HPV infection
in men. It is expected, though, that male vaccination rates will remain low. Therefore this …

Background While it is known that sub-Saharan African countries face multiple obstacles
such as cost in adopting vaccination against human papillomavirus (HPV), the crucial role …